Benzinga | May 13, 2021 06:20AM EDT

Haemonetics Q4 Adj. EPS $0.46 Misses $0.67 Estimate, Sales $225.03M Beat $222.98M Estimate

Haemonetics (NYSE:HAE) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.67 by 31.34 percent. This is a 33.33 percent decrease over earnings of $0.69 per share from the same period last year. The company reported quarterly sales of $225.03 million which beat the analyst consensus estimate of $222.98 million by 0.92 percent. This is a 5.65 percent decrease over sales of $238.49 million the same period last year.